Symbiotec Pharmalab Limited is a research-driven pharmaceutical and biotechnology company engaged in the development and manufacturing of Active Pharmaceutical Ingredients (APIs). The company has a strong presence in corticosteroid and steroidal-hormone APIs, along with capabilities in biotechnology, fermentation and complex injectables. The company operates an integrated manufacturing platform and serves pharmaceutical customers across international markets. Its business is supported by research and development capabilities, manufacturing infrastructure and regulatory approvals for global markets. Key Highlights Disclaimer This article is for informational and educational purposes only and should not be construed as…
Read MoreSymbiotec Pharmalab IPO
